Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
25.93
+0.16 (0.62%)
At close: Apr 8, 2026, 4:00 PM EDT
25.93
0.00 (0.00%)
After-hours: Apr 8, 2026, 4:00 PM EDT
Surrozen Market Cap
Surrozen has a market cap or net worth of $300.61 million as of April 8, 2026. Its market cap has increased by 642.97% in one year.
Market Cap
300.61M
Enterprise Value
215.47M
1-Year Change
642.97%
Ranking
Category
Stock Price
$25.93
Market Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $300.61M, an increase of 149.15%. That is a compound annual growth rate of 19.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 296.01M | 40.49% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 319.78M |
| Greenwich LifeSciences | 311.87M |
| AC Immune | 308.52M |
| LENZ Therapeutics | 304.45M |
| Inhibikase Therapeutics | 299.94M |
| Adagene | 292.70M |
| Foghorn Therapeutics | 291.74M |
| NovaBridge Biosciences | 285.92M |